Sherwin-Williams (NYSE:SHW) Stock Price Target Cut by Citigroup

Sherwin-Williams (NYSE:SHW) had its target price lowered by Citigroup from $400.00 to $370.00 in a report released on Thursday, Benzinga reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock. Citigroup‘s price objective indicates a potential upside of 12.31% from the company’s current price.

Several other research firms have also weighed in on SHW. Stephens reduced their price target on shares of Sherwin-Williams from $375.00 to $353.00 and set a “hold” rating for the company in a research report on Tuesday, September 22nd. KeyCorp initiated coverage on shares of Sherwin-Williams in a research report on Thursday, September 10th. They issued a “sector weight” rating on the stock. Bank of America boosted their target price on shares of Sherwin-Williams from $369.00 to $383.00 and gave the company a “neutral” rating in a research note on Friday, July 17th. Guggenheim reissued a “buy” rating and set a $375.00 target price (down from $400.00) on shares of Sherwin-Williams in a research report on Wednesday. Finally, Melius Research assumed coverage on shares of Sherwin-Williams in a research note on Tuesday, October 6th. They set a “hold” rating and a $367.00 price target for the company. Fifteen investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $377.67.

Sherwin-Williams Stock Performance

SHW stock traded up $8.66 during midday trading on Thursday, hitting $329.46. The company’s stock had a trading volume of 2,370,187 shares, compared to its average volume of 1,936,033. The stock’s 50-day moving average price is $330.16 and its 200 day moving average price is $333.38. The company has a quick ratio of 0.46, a current ratio of 0.73 and a debt-to-equity ratio of 2.16. Sherwin-Williams has a 1 year low of $289.86 and a 1 year high of $377.77. The stock has a market cap of $79.98 billion, a price-to-earnings ratio of 30.36, a PEG ratio of 2.63 and a beta of 1.08.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, October 27th. The specialty chemicals company reported $3.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.69 by ($0.06). The business had revenue of $6.86 billion for the quarter, compared to analysts’ expectations of $6.78 billion. Sherwin-Williams had a net margin of 11.01% and a return on equity of 67.97%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $3.59 earnings per share. On average, equities analysts forecast that Sherwin-Williams will post 12.07 EPS for the current year.

Insider Activity at Sherwin-Williams

In related news, insider Karl J. Jorgenrud sold 7,886 shares of Sherwin-Williams stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $368.30, for a total value of $2,904,413.80. Following the completion of the transaction, the insider directly owned 11,944 shares in the company, valued at approximately $4,398,975.20. The trade was a 39.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Justin Binns sold 13,500 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $352.70, for a total transaction of $4,761,450.00. Following the sale, the insider directly owned 21,937 shares in the company, valued at $7,737,179.90. The trade was a 38.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Sherwin-Williams

Large investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in Sherwin-Williams in the second quarter valued at about $6,100,083,000. Wellington Management Group LLP grew its stake in shares of Sherwin-Williams by 133.7% during the 2nd quarter. Wellington Management Group LLP now owns 2,784,679 shares of the specialty chemicals company’s stock valued at $958,821,000 after purchasing an additional 1,593,009 shares during the period. Amundi grew its stake in shares of Sherwin-Williams by 20.6% during the 1st quarter. Amundi now owns 2,200,895 shares of the specialty chemicals company’s stock valued at $705,497,000 after purchasing an additional 376,505 shares during the period. Bank of New York Mellon Corp purchased a new stake in shares of Sherwin-Williams during the 2nd quarter valued at about $547,097,000. Finally, Legal & General Group Plc purchased a new stake in shares of Sherwin-Williams during the 2nd quarter valued at about $459,652,000. 77.67% of the stock is owned by institutional investors.

Sherwin-Williams News Roundup

Here are the key news stories impacting Sherwin-Williams this week:

• Positive Sentiment: Management narrowed its FY26 adjusted EPS outlook range, potentially reducing uncertainty around the company’s earnings trajectory. The update followed the third-quarter report and appears to have provided some reassurance to investors. Sherwin-Williams Narrows FY26 Adjusted EPS Outlook Range
• Positive Sentiment: Third-quarter revenue rose 7.9% year over year to $6.86 billion, exceeding analysts’ expectations of $6.78 billion. Management also expects approximately $75 million in structural cost savings in 2027, which could support future margins and earnings growth. Sherwin-Williams Q3 2026 Earnings and Sales Growth
• Positive Sentiment: Sherwin-Williams continued its long record of shareholder returns, extending its dividend increase streak to 48 years. JPMorgan maintained an overweight rating, while UBS raised its price target to $370 and retained a neutral rating. UBS Sherwin-Williams Price Target Update
• Neutral Sentiment: Analyst target-price changes were mixed: JPMorgan reduced its target to $375 from $380, and DA Davidson cut its target to $390 from $400, while both firms’ targets remain above the current trading level. JPMorgan Sherwin-Williams Price Target Update
• Negative Sentiment: Adjusted third-quarter EPS was $3.63, below the $3.69 consensus estimate, as higher costs and margin pressure offset the revenue beat. The earnings disappointment caused the stock to gap lower and trade below its 200-day moving average, signaling continued near-term technical weakness. Sherwin-Williams Stock Breaks Below 200-Day Moving Average

About Sherwin-Williams

The Sherwin-Williams Company (NYSE: SHW) develops, manufactures, distributes and sells paints, coatings and related products. Its offerings include architectural paints, industrial coatings, wood finishes, protective coatings, automotive refinishing products, floor coatings and related supplies marketed under brands such as Sherwin-Williams, Valspar, Minwax, Krylon and Dutch Boy.

Founded in 1866 and headquartered in Cleveland, Ohio, Sherwin-Williams serves professional contractors, do-it-yourself consumers, industrial manufacturers, commercial businesses and other customers.